Immunotolerance-inducing effect on allogeneic T cells by HLA-G1 expressed on ECV304

ZHANG Cai-e,DENG Yun-hua,WU Xiong-wen,张彩娥,邓云华,吴雄文,韩军艳,杨惠军,梁智辉,龚非力
DOI: https://doi.org/10.3760/CMA.J.ISSN.0254-1785.2005.12.002
2005-01-01
Abstract:Objective To study the inhibitory effects of HLA-G1 expressed in ECV304 on the proliferation of allogeneic T cells.Methods The recombinant plasmid pcDNA3-HLA-G1 which contained a full-length cDNA of HLA-G1 was constructed, and the ECV304 cell was transfected with the pcDNA3-HLA-G1 by using the lipofectin transfection. The expressed HLA-G1 on the cell surface was checked by specific monoclonal antibody (G11E5) with indirect immunofluorescence assay and FCM. The HLA-G1 expressed in ECV304 was used as stimulator in co-culture with allogeneic T cells, to perform allogeneic T cell proliferation assay and to generate ECV304-specific alloreactive CTL. The proliferation of T cells and the CTL’s cytotoxicity against ECV304 were tested by the MTT method.Results The expression of HLA-G1 on the surface of the ECV304 was verified with the immunofluorescent staining of the pcDNA3-HLA-G1 transfected cells. The proliferation intensity of allogeneic T cells was significantly decreased after the HLA-G1 expressed in ECV304, as the stimulation index of co-culture of allogeneic T cells with plasmid pcDNA3 transfected ECV304 was 1.59±0.41, meanwhile it was 1.33±0.46 to pcDNA3-HLA-G1 transfected ECV304, with the difference being significant (P< 0.05). The cytotoxicity of allogeneic CTL was also inhibited by the HLA-G1 expressed on the targets, indicated by the specific lysis of specific CTL against pcDNA3-HLA-G1 transfected ECV304, which was (52.33±4.48) %, meanwhile the specific lysis against plasmid pcDNA3 transfected ECV304 was (64.81±3.07) %, with the difference being significant (P< 0.05). Furthermore, this inhibition was blocked by addition of HLA-G specific mAb (G11E5).Conclusions The expression of HLA-G1 in the ECV-304 cells can inhibit the proliferation and cytotoxicity of allogeneic T cells. Our results support the hypothesis that HLA-G1 bears the tolerance-inducing effects in allogeneic T cell reaction. It is hopeful that HLA-G1 provides an alternative tool to treat autoimmune diseases and to induce and maintain tolerance to allografts.
What problem does this paper attempt to address?